Home / About PPME / News

News

Switching from a brand-name antiepileptic drug to a generic is not associated with a higher risk of seizures

2011-08-31 A report in Clinical Pharmacology and Therapeutics provides further evidence that patients with epilepsy do not have a higher risk of seizures if they switch from th...
Read more

Epilepsy: medical concerns of prescribing generics

2011-08-31 Generic economicsGeneric medications are generally cheaper than their branded product counterparts and so prescribing these is encouraged as a cost-containment strat...
Read more

EMA and FDA to collaborate on biosimilars

2011-08-12 The EMA announced on 23 June 2011 that it had set up a new ‘cluster’ to collaborate with the FDA for the exchange of information on biosimilar drugs.Biosimilars join...
Read more

Teva grabs biopharmaceutical company Cephalon

2011-08-12 On 2 May 2011, Teva and Cephalon announced that they had unanimously approved a definitive agreement under which Teva will acquire all outstanding shares of Cephalon...
Read more

Influence these two factors and the use of generics will increase

2011-08-10 IntroductionAccording to Assistant Professor William Shrank of Harvard Medical School, Boston, USA, we may be able to increase the use of generic alternatives over b...
Read more

Generic warfarin as safe and effective as brand name

2011-08-10 In a study by Dr Francesco Dentali and colleagues a study of the literature found that generic warfarin was as safe as brand name warfarin [1].The use of generic dru...
Read more

The ‘Wise List’ - a Swedish drug formulary

2011-08-08 Research carried out by Lars Gustafsson and et al. [1] into the use and acceptance of a drug formulary used in Stockholm, Sweden, found that adherence to the ‘Wise L...
Read more

Actavis launches generic Olanzapine on ‘day one’ in four European countries

2011-06-16 On 5 May 2011, Actavis Group, Zug, Switzerland—the world’s fourth largest generic pharmaceutical company—launched Olanzapine tablets in Bulgaria, Hungary, Slovakia a...
Read more

Professor in Clinical Pharmacy

2011-05-18 SDU – Odense, DenmarkThe Institute of Public Health, Department of Clinical Pharmacology, invites applications for a position as full Professor in Clinical Pharmacy....
Read more

Actavis produces 10 million tablets for Japan in record time

2011-05-03 On 20 April 2011 in Barnstaple, UK, Actavis managed to deliver 10 million levothyroxine tablets within only 20 days. These tablets are used in the treatment of thyro...
Read more

Germany tightens controls on pharmaceutical prices

2011-04-26 The German government is contemplating pharmaceutical price control legislation as it battles soaring drug spending. On the one hand Germany is keen to promote the u...
Read more

Impact of generic substitution in Finland

2011-04-26 Mandatory generic substitution was introduced in Finland on 1 April 2003. A recent study compared the impact of generic substitution on both originator and generic p...
Read more

Last update: 2008-09-06 |  Go Back |  Print View

Designed by Zwebb. Powered by eZpublish